BioSpace News Archive

CVS Health Corporation will hold a conference call with analysts and investors on Friday, November 6, 2020, at 8:00 a.m. to discuss its financial results for the third quarter of 2020.

NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced its unaudited revenue for the third quarter of 2020.

During the 2020 ASTRO Annual Meeting, taking place online October 23-29, Sun Nuclear is highlighting a range of solutions clinics can leverage to ensure continuity for their Quality Management programs.

Patients with diabetic kidney disease can potentially be treated with a new investigational medication that may slow the progress of their illness without harmful side effects to their hearts, according to the results of a global clinical trial announced

In the news release, BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate, issued Oct. 23, 2020 by BiondVax Pharmaceuticals Ltd. over PR Newswire, we are advised by the company that the Forward Looking Statements were not included. The complete, corrected release follows: BiondVax Announces Topline Results from P

As we continue to address the health, social, and economic impacts of COVID-19, the Government of Canada is actively pursuing the purchase and development of vaccines, treatments, and related supplies to protect Canadians from the virus and support our recovery from the pandemic

Entos Pharmaceuticals (Entos), a healthcare biotechnology company developing nucleic acid medicines with its breakthrough proprietary Fusogenix drug delivery platform, is pleased to announce it is receiving advisory services and funding of up to $5M from the National Research Council of Canada Industrial Research Assistance Program

Leading emergency medicine researchers will be on hand for the American College of Emergency Physicians (ACEP) Research Forum, part of ACEP20, the world’s largest emergency medicine conference

Canadian government to provide $173M in funding for vaccine research and development, and domestic manufacturing capacity

AMCP Foundation hosted its most recent Best Poster Competition at AMCP Nexus 2020 Virtual on Wednesday, Oct. 21.